$47.58▲ 1.86 (4.07%)
Real-time prices · US MarketsQ·Score
Underperform
4.2 / 10
Clean balance sheet with low leverage (0.2× debt-to-equity).
currently unprofitable (-145% margin).
Quality
0.2
Health
9.7
Growth
5.1
Valuation
3
Sentiment
3.7
Analyst Target
$41.42
▼ 12.9% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
—
price-to-earnings
Forward P/E
-10.1×
next 12 months est.
Market Cap
$18.9B
market capitalization
Div Yield
—
dividend yield
Profit Margin
-145.2%
net profit margin
Gross Margin
-105.8%
revenue minus COGS
ROE
-28.9%
return on equity
Beta
1.34
vs S&P 500
Price / Book
—
P/B ratio
52-Week Range
$22 — $60
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
Is MRNA a good stock to buy right now?
Based on our Q·Score of 4.2/10, Moderna, Inc. is rated "Underperform". Clean balance sheet with low leverage (0.2× debt-to-equity). Main risk to consider: currently unprofitable (-145% margin). This analysis is based on fundamentals, analyst consensus, and valuation data, and should not be considered financial advice.
What is the analyst price target for MRNA?
The consensus price target for MRNA is $41.42, based on the recommendations of 19 Wall Street analysts. This implies 12.9% downside from the current price of $47.58.
Is MRNA overvalued or undervalued?
Moderna, Inc. (MRNA) appears to be trading at a premium relative to analyst targets and sector peers. The consensus target of $41.42 is below current price, suggesting limited upside.
When does Moderna, Inc. report its next earnings?
Moderna, Inc. is scheduled to report earnings tomorrow (May 1, 2026).
What is Moderna, Inc.'s profit margin?
Moderna, Inc. has a net profit margin of -145.2%, indicating the company is currently operating at a net loss. Its gross margin stands at -105.8%, reflecting a more cost-intensive business model.
Is Moderna, Inc.'s revenue growing?
Moderna, Inc. is reporting revenue declining 29.8% year-over-year.
How much debt does Moderna, Inc. have?
Moderna, Inc. has a debt-to-equity ratio of 0.15×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 3.29×, indicating comfortable short-term liquidity.